Reviewing NovelStem International (NSTM) & Its Rivals

NovelStem International (OTCMKTS:NSTM) is one of 26 public companies in the “Retail stores, not elsewhere classified” industry, but how does it contrast to its competitors? We will compare NovelStem International to related businesses based on the strength of its profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation.

Risk & Volatility

NovelStem International has a beta of 0.32, indicating that its stock price is 68% less volatile than the S&P 500. Comparatively, NovelStem International’s competitors have a beta of 0.74, indicating that their average stock price is 26% less volatile than the S&P 500.

Institutional and Insider Ownership

29.3% of shares of all “Retail stores, not elsewhere classified” companies are owned by institutional investors. 13.6% of NovelStem International shares are owned by insiders. Comparatively, 16.9% of shares of all “Retail stores, not elsewhere classified” companies are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for NovelStem International and its competitors, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NovelStem International	0	0	0	0	N/A
NovelStem International Competitors	88	811	1393	55	2.60

As a group, “Retail stores, not elsewhere classified” companies have a potential upside of 13.50%. Given NovelStem International’s competitors higher probable upside, analysts clearly believe NovelStem International has less favorable growth aspects than its competitors.

Profitability

This table compares NovelStem International and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NovelStem International	-9,166.67%	N/A	-73.18%
NovelStem International Competitors	-25.06%	-60.82%	-0.94%

Earnings and Valuation

This table compares NovelStem International and its competitors revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
NovelStem International	$10,000.00	-$4.19 million	-0.25
NovelStem International Competitors	$8.78 billion	$125.13 million	6.28

NovelStem International’s competitors have higher revenue and earnings than NovelStem International. NovelStem International is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

NovelStem International competitors beat NovelStem International on 9 of the 10 factors compared.

NovelStem International Company Profile

NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is headquartered in Boca Raton, Florida.